India supplies nearly 30% of global generic medicines as the government promotes wider domestic use to reduce patients treatment costs.​ India Strengthens Global Generic Drug Supply India currently supplies nearly 30% of generic medicines used worldwide, according to Union Minister of State for Health and Family Welfare Anupriya Patel. Speaking during Question Hour in the Lok Sabha, the minister said the country remains a leading m

The FDA has classified a nationwide levothyroxine recall involving select Major Pharmaceuticals tablets after potency testing found some lots contained less active ingredient than required. The action covers multiple strengths and package sizes used for thyroid treatment. Nationwide levothyroxine recall The U.S. Food and Drug Administration has classified a nationwide recall involving select lo

A nationwide cetirizine recall covers four lots of 5 mg allergy tablets distributed by Rising Pharma after red dots and discoloration suggested possible ranitidine contamination. Consumers should check lot numbers, watch for severe allergic reactions and report problems. Unique Pharmaceutical Laboratories has voluntarily recalled four lots of Cetirizine Hydrochloride Tablets USP 5 mg at the consumer level because of potent

Trump's generic drug tariff plan introduces a phased import duty that could reach 200% within three years, encouraging pharmaceutical companies to manufacture in the United States. The proposal could significantly affect India's pharmaceutical industry, which supplies nearly 40% of generic medicines used in the US. Trump Generic Drug Tariffs Target India Pharma Export

The Indian government has taken another major step to improve medicine safety by making QR codes mandatory on several categories of critical drugs, including vaccines, anti-cancer medicines, antimicrobials, and narcotic medications. The move is aimed at helping consumers and healthcare providers easily verify the authenticity of medicines and reducing the spread of counterfeit and substandard drugs in the country. The Union Health Ministry

India and the United States are edging closer to a structured trade agreement after fresh negotiations indicated reduced gaps on several contentious issues. US officials described the discussions as the most constructive phase so far, suggesting that a framework deal is now within reach, even though final clearance is still pending. The talks are part of a broader effort to establish a long-term Bilateral Trade Agreement aimed at improving market access, easing tariff friction, and stabilizing supply chain cooperation between the two economies. Tariff reduction and market access remain central issues At the core of the negotiations are tariff structures and access to each other’s markets. The United States is pushing for wider entry for industrial and agricultural goods, while India is focused on protecting sensitive domestic sectors while expanding export opportunities in technology, textiles, and pharmaceuticals. Both sides are trying to balance domestic political pressures with the need to expand bilateral trade volumes, which currently remain below their long-term potential despite strong economic ties. Digital trade and pharmaceutical rules under review A significant portion of the discussion is now centered on digital trade regulations and pharmaceutical standards. The US is seeking clearer digital data flow rules and stronger intellectual property protections, while India is prioritizing flexibility for its growing digital economy and affordable healthcare exports. Pharmaceutical trade remains a key pillar, with India seeking smoother regulatory pathways for generic drug exports, while the US is focusing on compliance and quality standard alignment. Strategic economic alignment driving urgency The urgency behind the negotiations is being shaped by global supply chain realignment and geopolitical competition. Both countries are increasingly aligning their trade policies within the Indo-Pacific framework, with an emphasis on reducing dependency on concentrated manufacturing hubs. India is positioning itself as an alternative global manufacturing base, while the US is looking to diversify sourcing and strengthen resilient supply networks. Next phase depends on unresolved policy gaps Despite visible progress, the agreement is not finalized. Several policy differences still need resolution, particularly around tariff ceilings, digital governance, and sector-specific protections. Officials from both sides are expected to continue technical-level discussions before moving toward a formalized trade framework. A final agreement timeline has not been confirmed, but momentum suggests continued acceleration in the coming months.

Two workers killed in factory fire At least two workers were killed after a major fire broke out at a chemical manufacturing unit in Paravada Pharma City near Visakhapatnam early on Tuesday, Jun 23, 2026. The accident took place at Dakshin Energy Chemical Factory in Anakapalle district, triggering panic in the industrial area as flames spread through the premises. The deceased workers have been identified as Trinadh and Venkatesh, both reportedly from Ac

Government restricts cough syrup sales under new prescription rule The Government of India has introduced a strict regulatory change that makes cough syrups and other medicinal syrup-based formulations available only against a valid prescription from a registered medical practitioner. The decision comes through an amendment to the Drugs Rules, 1945, and represents a major shift in how over-the-counter medi

Strengthening India-Venezuela Relations Prime Minister Narendra Modi held a high-level meeting with Venezuela's Acting President Delcy Rodriguez in New Delhi on Thursday. The meeting took place at Hyderabad House, where both leaders discussed the full spectrum of India-Venezuela relations. Key focus areas included energy security, trade and investment, pharmaceuticals, healthcare, transportation, and renewabl

South Africa’s Deputy President Shipokosa Paulus Mashatile said India remains a reliable partner as he pushed for deeper India-South Africa trade ties during a working visit to New Delhi. Mashatile used the New Delhi leg of his six-day visit to invite Indian companies to expand investment in South Africa, especially in clean energy, pharmaceuticals, ICT, automotive components, infrastructure, agriculture and agro-processing. Mashatile seeks stronger India-South

The White House says aligning U.S. drug prices with global rates may slash costs—but experts remain divided. What the $529 Billion Savings Really Means According to White House economists, Trump’s drug pricing strategy—often called the “most favored nation” model—could reduce prescription drug costs by up to $529 billion over 10 years. The idea is simple: Americans s

GLP-1 Drugs Drive Pharma Growth GLP-1 weight loss drugs are powering a sharp rebound in pharma R&D returns, but analysts warn the boom may be creating a risky “bubble effect” across the sector. According to Deloitte’s latest pharma innovation analysis, R&D returns among the world’s top 20 drugmakers have climbed to 7%, driven largely by obesity and diabetes treatments such as GLP-1 drugs. Obesity Drugs Overtake Oncology

A newly announced policy introducing tariffs on certain imported pharmaceuticals could gradually increase prescription drug costs for patients across the United States. The measure applies primarily to brand-name medications that remain under patent, along with some of their active ingredients, with tariff rates potentially reaching up to 100 percent depending on compliance with pricing or domestic production conditions. While generic medications and biosimilars are currently exclud

​REDWOOD CITY, California — Revolution Medicines announced positive results from a late-stage clinical trial evaluating its experimental drug daraxonrasib, showing a significant survival benefit for patients with advanced pancreatic cancer who had previously undergone treatment. According to the company, patients receiving the once-daily oral therapy lived a median of 13.2 months, compar

A California-based pharmaceutical company has expa

President Donald Trump’s recently announced agreements with pharmaceutical companies are expected to have a limited effect on what most Americans pay for prescription drugs, according to health policy experts who say the scope and structure of the deals leave many patients unaffected. Since Sept. 30, the Trump administration has reached agreements with 14 drugmakers in exchange for relie

Eli Lilly reached a historic milestone on Friday when it briefly surpassed a $1 trillion market capitalization, becoming the first health-care company in the world to enter a territory long dominated by technology giants. The company’s stock hovered near $1,048 per share during morning trading, touching the trillion-dollar threshold before pulling back slightly. It is only the second nontechnology business in the United States to reach this valuation, following Berkshire Hathaway’s climb

A senior pharmaceutical executive collapsed during an Oval Office event where former U.S. President Donald Trump was announcing a new initiative to reduce the prices of obesity drugs. The incident caused a sudden interruption to the live broadcast of the announcement, which was centered on a major agreement between the Trump administration and leading pharmaceutical manufacturers. According to eyewitnesses, the executive, later identified as Gordon Findlay of Novo Nordisk, lost his

Washington: US President Donald Trump has announced sweeping new tariffs on imported pharmaceutical products, a move that could trigger widespread consequences for the global drug trade and India’s pharmaceutical sector in particular. Effective October 1, 2025, Washington will impose tariffs of up to 100 percent on branded and patented pharmaceutical drugs unless the manufacturing companies are building their production facilities within the United States. The president emphasized that

Walmart has confirmed that its Neighborhood Market at 3112 Santa Rita Road will close on October 2. The store’s pharmacy will also shut down on the same date. Walmart spokesperson Anne Hatfield did not give a specific reason for the closure, but noted there are three Walmart locations within eight miles of the Pleasanton market including a full-service Walmart in Livermore and a newly remodeled Neighborhood Marke